D LNs at day 21, 35, 49 after immunization (B). Representative flow Information of CD4+Foxp3+ frequency in joint synovial fluid of GMSC-treated CIA mice (C). Frequency and total numbers of CD4+Foxp3+ in joint synovial fluid of GMSC-treated mice (D). Information in B and D are presented because the mean ?SEM of two separate experiments (n=6). P0.05 versus untreated group.Arthritis Rheum. Author manuscript; offered in PMC 2015 March 18.Chen et al.PageAuthor Manuscript Author Manuscript Author Manuscript Author ManuscriptFigure four.GMSCs raise the frequency of iTregs but not nTregs in CIA model, the majority of which are CD4+Foxp3+(GFP+)CD39+Helios- Treg cells. Foxp3gfp reporter DBA/1 mice have been immunized with CII and CFA. 2?06 GMSCs had been injected to mice by way of tail vein on 14 days following CII immunization. Mice have been sacrificed just after a week. Every single experiment incorporates five mice per group and experiment was repeated twice. A, Representative flow cytometric data with the Heilos expression in draining LNs. Cells were gated on CD4 optimistic cells. The frequency of CD4+Foxp3+Helios+ cells in draining LNs is shown within the right panel. B, Frequency of CD4+CD39+ cells in the spleens, LNs and blood. C, Frequency of CD4+Foxp3+CD39+ or CD4+Foxp3-CD39+ cells within the spleens and LNs. D, Representative flow cytometric data of CD39+Foxp3+ cell frequency gated on CD4+ cells within the spleens and LNs. Values within a, B and C had been imply ?SEM of two separate experiments (n=5). P0.05, P0.01 versus the untreated group.Arthritis Rheum. Author manuscript; accessible in PMC 2015 March 18.Chen et al.PageAuthor Manuscript Author Manuscript Author Manuscript Author ManuscriptFigure five.GMSCs attenuate the inflammation of arthritis, which partially depends on the regulatory T cells. A, DBA/1 Foxp3gfp reporter mice have been immunized with CII/CFA. At day 7, mice were injected i.p. with PC61 (anti-CD25 monoclonal antibody) 250 g/mouse or handle PBS. CD4+Foxp3+ cell frequency (mean ?SEM) was counted in the spleens on time-points as indicated. Every experiment consists of five mice per group and experiment was repeated twice. P0.05, P0.01 versus the PC61 therapy group. B-D, DBA/1 mice have been immunized with CII/CFA, and/or followed by PC61 i.p. injection on day 7 and/or followed by i.v. 2?06 GMSC infusion on day 14. Incidence of arthritis and clinical arthritis scores (B). H E CA125 Protein supplier stained sections and evaluation of synovitis, pannus formation, and erosion of tarsal joints in CIA mice. Scale bar, 200 m. MIF Protein site Pathology scores of H E sections in every group were shown within the ideal panel (C). Typical frequency of IFN+ and IL-17+ cells within the spleens and draining LNs (D). Data in B, C and D are presented as the mean ?SEM of two separate experiments (n=6). P0.05, P0.01 versus the GMSCs+PC61 group, or versus the PC61 group.Arthritis Rheum. Author manuscript; offered in PMC 2015 March 18.Chen et al.PageAuthor Manuscript Author Manuscript Author ManuscriptFigure six.Author ManuscriptGMSCs attenuate inflammation responses in CIA mice through CD39 and/or CD73 signals. A, Analysis of GMSCs surface proteins by Flow cytometry. Fifth-passage GMSCs were stained with antibodies as indicated. B-D, DBA/1 mice were immunized with CII/CFA. 2?06 GMSCs pretreated with or without APCP (one hundred M) or POM-1 (one hundred M) overnight have been injected i.v. into DBA/1 mice on day 14 right after CII immunization (n=6 every single group and experiment was repeated twice). Incidences of arthritis of DBA/1 mice (B). Clinical arthritis scores inside the indicated groups. The data are presented as t.